Nanovery raises €1.3M Seed round

10 April 2025· Newcastle upon Tyne, United Kingdom· health, oncology, biotech, ai, b2b, deep_hardware

The funding will help advance the growth and adoption of Nanovery's analytical platform, which simplifies and accelerates the testing process for RNA therapeutics.

Investors

LeadNorthstar Ventures
Also participating
Innovate UKSmartlink Partners

About Nanovery

Stage
Seed
Headquarters
Newcastle upon Tyne, United Kingdom
Founded
2018
Team Size
6–20
Sectors
healthoncologybiotechaib2bdeep_hardware

Source: https://www.northstarventures.co.uk/news/essential-disease-detection-and-advanced-drug-development-takes-another-stride-forward-with-1-1m-funding-boost-for-nanovery/